Head R&D Strategic Evaluation, Global Drug Development, at MorphoSys
Bianca Wittig is a(n) Head R&D Strategic Evaluation, Global Drug Development, working at MorphoSys.
Get Bianca Wittig's email for freeName | Position | Contacts | ||
---|---|---|---|---|
CL | Charlotte Lohmann | Executive Committee Member, Senior Vice President & General CounselMorphoSys | @mor….com089 8 | Get contact |
ED | Elizabeth Dileo | Clinical Trial ManagerMorphoSys | @mor….com089 8 | Get contact |
JJ | Justyna Justyna | Manager CMC Regulatory AffairsMorphoSys | @mor….com089 8 | Get contact |
EL | Emanuel Lohrmann | Senior Director Drug SafetyMorphoSys | @mor….com089 8 | Get contact |
KK | Krishna Kadiyala | Vice President, Head of Business Operations and InnovationMorphoSys | @mor….com089 8 | Get contact |
DN | David Nganele | Highly accomplished senior director with 20+ years of global experience in all aspectsMorphoSys AG | @mor….com+49 8 | Get contact |
MW | Mark Winderlich | Associate Director Biostatistics, Clinical DevelopmentMorphoSys AG | @mor….com+49 8 | Get contact |
MC | Martin Clark | Vice President, Head of Central Purchasing and LogisticsMorphoSys AG | @mor….com+49 8 | Get contact |
FS | Frank Striebel | ScientistMorphoSys AG | @mor….com+49 8 | Get contact |
DD | Daniela Ducata | Senior ScientistMorphoSys AG | @mor….com+49 8 | Get contact |